Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

GENEVA--(BUSINESS WIRE)--Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales.

Business Wire • 3 hours ago

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

GENEVA--(BUSINESS WIRE)--Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales.

Business Wire • 3 hours ago

Gear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Alcon (ALC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

Zacks Investment Research • Feb 19, 2026

Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology

GENEVA--(BUSINESS WIRE)--Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology.

Business Wire • Feb 17, 2026

Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

TORONTO--(BUSINESS WIRE)-- #AlconCanada--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the Canadian launch of PRECISION7® sphere and toric, the only one-week replacement contact lens with the revolutionary ACTIV-FLO® System2,5 that provides 16 hours of outstanding comfort and precise vision, even on day 7.1 The lenses will be commercially available in Canada in February. While nearly nine out of ten Eye Care Professionals (ECPs) believe daily.

Business Wire • Feb 2, 2026

Alcon Completes $750 Million Share Repurchase Program

GENEVA--(BUSINESS WIRE)--Alcon Completes $750 Million Share Repurchase Program.

Business Wire • Jan 20, 2026

Alcon Inc. (ALC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Alcon Inc. (ALC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 13, 2026

Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to secure enough shareholder votes to approve the deal, sending its shares down more than 12%.

Reuters • Jan 6, 2026

STAAR Surgical Merger With Alcon Fails After Shareholders Vote No

STAAR Surgical Company (NASDAQ: STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon Inc. (NYSE: ALC) at the Special Meeting of Stockholders.

Benzinga • Jan 6, 2026

Alcon Terminates Agreement to Acquire STAAR Surgical

GENEVA--(BUSINESS WIRE)--Alcon Terminates Agreement to Acquire STAAR Surgical.

Business Wire • Jan 7, 2026